RT Journal Article
T1 Conjunctivitis in COVID-19 patients: frequency and clinical presentation
A1 Güemes Villahoz, Noemi
A1 Burgos Blasco, Bárbara
A1 García Feijoo, Julián
A1 Sáenz Francés, Federico
A1 Arriola Villalobos, Pedro
A1 Martínez de la Casa, José María
A1 Benítez del Castillo, José Manuel
A1 Herrera de la Muela, María
AB Purpose: The purpose of this study was to evaluate the frequency and clinical presentation of conjunctivitis in hospitalized patients with COVID-19.Methods: A cross-sectional study was conducted at the Hospital Clinico San Carlos of Madrid, Spain. A total of 301 subjects from the COVID admission unit with laboratory-confirmed SARS-CoV-2 infection were included. The presence and clinical characteristics of conjunctivitis were evaluated. Laboratory, radiological, and clinical results in patients with and without conjunctivitis stratified by sex were analyzed.Results: Of the 301 subjects included, 180 patients (59.8%) were male and the median age was 72 years (IQ 59–82). Overall, 35 patients (11.6%) were diagnosed with acute conjunctivitis. We found no relationship between the COVID-19 severity score and the presence of conjunctivitis (P = 0.17). However, conjunctivitis was more frequent in males with moderate clinical severity and in women classified as clinically mild. The natural history of the disease seems to be a rapid self-limited conjunctivitis that improves without treatment and does not affect visual acuity nor associate short-term complications.Conclusions: Approximately, 1 out of 10 hospitalized non-critical COVID-19 patients presents conjunctivitis during the disease. Compared with other viral conjunctivitis, we found distinctive clinical findings that could guide defining and differentiating conjunctivitis in COVID-19 patients.
PB Springer
SN 0721-832X
YR 2020
FD 2020-08-29
LK https://hdl.handle.net/20.500.14352/6493
UL https://hdl.handle.net/20.500.14352/6493
LA eng
NO Received: 1 June 2020 / Revised: 20 July 2020 /Accepted: 25 August 2020
DS Docta Complutense
RD 2 may 2024